Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free COSM Stock Alerts

Cosmos Health (COSM) Competitors

Cosmos Health logo
$0.32 +0.02 (+7.26%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.32 +0.01 (+1.64%)
As of 09/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

COSM vs. YI, MEDS, RDGT, HKPD, and MCK

Should you buy Cosmos Health stock or one of its competitors? Cosmos Health's main competitors and comparable companies include 111 (YI), Wellgistics Health (MEDS), Ridgetech (RDGT), Hong Kong Pharma Digital Technology (HKPD), and McKesson (MCK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Cosmos Health compare to 111?

111 (NASDAQ:YI) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

21.3% of 111 shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 43.9% of 111 shares are owned by company insiders. Comparatively, 26.2% of Cosmos Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, 111 had 7 more articles in the media than Cosmos Health. MarketBeat recorded 8 mentions for 111 and 1 mentions for Cosmos Health. 111's average media sentiment score of 0.47 beat Cosmos Health's score of 0.29 indicating that 111 is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
111
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cosmos Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

111 has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, meaning that its share price is 380% more volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
111
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

111 has a net margin of -1.01% compared to Cosmos Health's net margin of -33.08%. 111's return on equity of 0.00% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
111-1.01% N/A -4.86%
Cosmos Health -33.08%-56.88%-18.03%

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
111$1.80B0.02-$9.65M-$1.40N/A
Cosmos Health$65.27M0.49-$19.15M-$0.64N/A

Summary

111 beats Cosmos Health on 9 of the 13 factors compared between the two stocks.

How does Cosmos Health compare to Wellgistics Health?

Wellgistics Health (NASDAQ:MEDS) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

5.7% of Wellgistics Health shares are held by institutional investors. Comparatively, 12.6% of Cosmos Health shares are held by institutional investors. 29.1% of Wellgistics Health shares are held by insiders. Comparatively, 26.2% of Cosmos Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cosmos Health has a net margin of -33.08% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Wellgistics Health-1,100.16% N/A -171.81%
Cosmos Health -33.08%-56.88%-18.03%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Cosmos Health has higher revenue and earnings than Wellgistics Health. Cosmos Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellgistics Health$23.34M0.52-$101.28M-$46.13N/A
Cosmos Health$65.27M0.49-$19.15M-$0.64N/A

Wellgistics Health has a beta of -1.77, indicating that its stock price is 277% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, indicating that its stock price is 380% more volatile than the broader market.

In the previous week, Wellgistics Health had 15 more articles in the media than Cosmos Health. MarketBeat recorded 16 mentions for Wellgistics Health and 1 mentions for Cosmos Health. Cosmos Health's average media sentiment score of 0.29 beat Wellgistics Health's score of 0.05 indicating that Cosmos Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Wellgistics Health
0 Very Positive mention(s)
0 Positive mention(s)
16 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cosmos Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Cosmos Health beats Wellgistics Health on 8 of the 13 factors compared between the two stocks.

How does Cosmos Health compare to Ridgetech?

Cosmos Health (NASDAQ:COSM) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ridgetech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Cosmos Health had 1 more articles in the media than Ridgetech. MarketBeat recorded 1 mentions for Cosmos Health and 0 mentions for Ridgetech. Cosmos Health's average media sentiment score of 0.29 beat Ridgetech's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media.

Company Overall Sentiment
Cosmos Health Neutral
Ridgetech Neutral

Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market.

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by company insiders. Comparatively, 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Ridgetech has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Ridgetech's return on equity of 0.00% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cosmos Health-33.08% -56.88% -18.03%
Ridgetech N/A N/A N/A

Ridgetech has higher revenue and earnings than Cosmos Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cosmos Health$65.27M0.49-$19.15M-$0.64N/A
Ridgetech$132.16M0.02-$1.25MN/AN/A

Summary

Ridgetech beats Cosmos Health on 6 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hong Kong Pharma Digital TechnologyN/A N/A N/A
Cosmos Health -33.08%-56.88%-18.03%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

12.6% of Cosmos Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Cosmos Health had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 1 mentions for Cosmos Health and 0 mentions for Hong Kong Pharma Digital Technology. Cosmos Health's average media sentiment score of 0.29 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the news media.

Company Overall Sentiment
Hong Kong Pharma Digital Technology Neutral
Cosmos Health Neutral

Hong Kong Pharma Digital Technology has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hong Kong Pharma Digital Technology$13.43M0.09-$1.14MN/AN/A
Cosmos Health$65.27M0.49-$19.15M-$0.64N/A

Summary

Cosmos Health beats Hong Kong Pharma Digital Technology on 7 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to McKesson?

Cosmos Health (NASDAQ:COSM) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cosmos Health$65.27M0.49-$19.15M-$0.64N/A
McKesson$403.43B0.25$4.76B$37.3723.39

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -33.08%. Cosmos Health's return on equity of -56.88% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Cosmos Health-33.08% -56.88% -18.03%
McKesson 1.12%-253.21%5.90%

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cosmos Health has a beta of 4.8, meaning that its share price is 380% more volatile than the broader market. Comparatively, McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

In the previous week, McKesson had 13 more articles in the media than Cosmos Health. MarketBeat recorded 14 mentions for McKesson and 1 mentions for Cosmos Health. McKesson's average media sentiment score of 0.62 beat Cosmos Health's score of 0.29 indicating that McKesson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cosmos Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
McKesson
5 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson has a consensus price target of $973.44, indicating a potential upside of 11.37%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Cosmos Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cosmos Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
McKesson
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.78

Summary

McKesson beats Cosmos Health on 12 of the 16 factors compared between the two stocks.

Get Cosmos Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for COSM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COSM vs. The Competition

Export
MetricCosmos HealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$31.98M$9.75B$7.24B$13.19B
Dividend YieldN/A2.62%2.57%12.81%
P/E Ratio-0.5034.09275.4925.40
Price / Sales0.494.98646.0189.45
Price / CashN/A121.7676.2551.42
Price / Book0.715.3010.466.33
Net Income-$19.15M$313.45M$3.49B$358.33M
7 Day Performance25.32%1.65%0.59%1.12%
1 Month Performance51.33%-0.85%-1.74%-2.39%
1 Year Performance-66.66%16.30%18.13%5.35%

Cosmos Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COSM
Cosmos Health
1.2226 of 5 stars		$0.32
+7.3%		N/A-66.7%$31.98M$65.27MN/A163
YI
111
0.5903 of 5 stars		$3.49
-0.3%		N/A-31.7%$30.68M$1.80BN/A1,063
MEDS
Wellgistics Health
0.3378 of 5 stars		$1.62
+87.2%		N/A-94.5%$5.18M$23.34MN/A31
RDGT
Ridgetech
0.8129 of 5 stars		$0.82
-2.6%		N/A-99.6%$2.96M$132.16MN/A980
HKPD
Hong Kong Pharma Digital Technology
0.7907 of 5 stars		$0.11
-9.3%		N/A-91.5%$1.25M$13.43MN/A19

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:COSM) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners
$40,000,000,000,000
The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...
American Alternative | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
“Elon’s nightmare” could fund your retirement
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Iran War: Why Is Trump Protecting THEM?
A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...
Banyan Hill Publishing | Sponsoredtc pixel
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...
Paradigm Press | Sponsoredtc pixel